Found 81 matching trials
Neoepitope-based Personalized Vaccine Approach in Patients With Newly Diagnosed Glioblastoma PHASE1 The early clinical development paradigm for chemotherapeutic agents has sig...
Show More Location
Washington University School of Medicine
Learn More & Join Trial
Personalized Neoantigen Peptide Vaccines for Solid Tumors PHASE1 This clinical trial is studying the safety and efficacy of a personalized c...
Show More Location
Horizon Cancer Excellence Center, Bumrungrad International Hospital
Learn More & Join Trial
Individualized Neoantigen Therapy with Unusual Radiotherapy Enhancement (iNATURE) PHASE2 In this study, the investigators provide an individualized tumor neoantigen...
Show More Location
University of Hong Kong-Shenzhen Hospital
Learn More & Join Trial
Clinical Study for the Safety and Therapeutic Efficacy of the AI-QMMM Designed TamavaqTM Personalised Vaccine in Patients With Newly Diagnosed Glioma. EARLY_PHASE1 Gliomas are a heterogeneous group of tumors arising from glial cells in the...
Show More Location
Biogenea Pharmaceuticals Ltd
Learn More & Join Trial
NeoVax + CDX-301 and Nivolumab or Pembrolizumab in Melanoma PHASE1 This research study is studying the drugs called NeoVax (a new type of pers...
Show More Status
Active Not Recruiting
Location
Dana-Farber Cancer Institute
Learn More & Join Trial
Application of MRD Combined With Personalized Vaccine in the Treatment of Postoperative Recurrence Prevention of EOC PHASE2 The goal of this clinical trial is as follows:(1) Establish a clinical tech...
Show More Location
Second Affiliated Hospital of Wenzhou Medical University
Learn More & Join Trial
Autologous Neoantigen-Specific T-Cell Therapy for Advanced Hepatocellular Carcinoma PHASE1 The goal of this open-label, single-arm phase I/II clinical trial is to eva...
Show More Location
The First Affiliated Hospital, Zhejiang University School of Medicine
Learn More & Join Trial
Personalized Vaccination in Fusion+ Sarcoma Patients (PerVision) PHASE1 The PerVision trial utilizes an approach of a patient-individual cancer vac...
Show More Location
Pediatrics III, West German Cancer Centre, University Hospital
Learn More & Join Trial
Safety and Immunogenicity of a Personalized Synthetic Long Peptide Breast Cancer Vaccine Strategy in Patients With Persistent Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy PHASE1 The most important consideration in the design of this clinical trial is to...
Show More Location
Multiple Locations
Learn More & Join Trial
PEP-DC and OC-DC Vaccine in High Grade Serous Ovarian Carcinoma PHASE1 Single center, phase I/II randomized 2-arm study, evaluating two different ...
Show More Location
Multiple Locations
Learn More & Join Trial